A randomised, placebo-controlled phase 3 study of plozasiran in patients with familial chylomicronemia syndrome
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
University of Western Australia, Perth (Australia)
4 More presentations in this session
Doctor Y. Kang (Boston, US)
Doctor G. Chi (Boston, US)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
You may be interested in
Congress Presentation
Congress Presentation
